References

Nanocan’s inaugural innovation derives from its worldwide exclusive license for Immunogenic Smart Radiotherapy Biomaterial (iSRB) technology. Read about the licensing of its iSRB technology here.
Publications on the iSRB technology are listed below:

Copyright © 2021 Nanocan Therapeutics Corporation - All Rights Reserved.